ClinicalTrials.gg
RecruitingNCT07022210Updated Jul 10, 2025

Incidence of Hypotension in the Post-anesthesia Care Unit (PACU).

An observational study in Hypotension During Surgery and Surgery-Complications, sponsored by Tomas Bata Hospital, Czech Republic. Recruiting at 1 site in Czechia. Open to participants aged 18 Years to 105 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by Tomas Bata Hospital, Czech Republic · Observational

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 105 Years
Sex
All
01

Study summary

The perioperative period poses a heightened risk of complications for patients, including hypotension. While the issue of intraoperative hypotension is well-documented in medical literature, the occurrence and causes of hypotension in the post-anesthesia care unit often receive less attention. This phase of postoperative care, however, is vital for ensuring patient stability and preventing severe consequences. Failure to identify and manage a drop in blood pressure can lead to hypoperfusion of critical organs, increasing the risk of morbidity and mortality. The aim of this study is to examine the frequency of hypotension in the post-anesthesia care unit-defined as systolic blood pressure \<90 mmHg or a drop of more than 20% from baseline-and to identify factors contributing to its development.

Read the detailed description

The perioperative period is a critical time for patients, marked by an increased risk of various complications, including hypotension. While intraoperative hypotension is extensively studied in medical literature, the occurrence and underlying causes of hypotension in the post-anesthesia care unit (PACU) often remain overlooked. This phase of postoperative care is essential for stabilizing the patient and preventing severe outcomes. A failure to identify and adequately address a drop in blood pressure during this time can result in hypoperfusion of vital organs, increasing the likelihood of morbidity and mortality.

Hypotension in the PACU is defined as a systolic blood pressure below 90 mmHg or a decrease exceeding 20% compared to the patient's baseline measurements. The aim of this research is to explore the prevalence of hypotension in the PACU and to analyze the factors contributing to its occurrence. By improving the understanding of this issue, the study seeks to enhance patient outcomes through timely identification and management of hypotension in this crucial phase of care.

02

Conditions studied

  • Hypotension During Surgery
  • Surgery-Complications

Browse trials for

Keywords

  • hypotension
  • post-anesthesia care unit
  • surgery
  • adult
03

In context

Hypotension

892 studies on the registry are indexed under Hypotension; 199 are open to participants now.

This study's planned enrollment of 100 is close to the median of 93 across 269 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Tomas Bata Hospital, Czech Republic is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 105 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients meeting the inclusion criteria, aged 18 to 105 years, with an indicated hospitalization at a diagnostic-therapeutic unit (DTU).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients over 18 years old
  • patients undergoing a procedure under general anesthesia
  • patients who have consented to data processing
  • postoperative stay in PACU

Exclusion criteria

Exclusion Criteria:

  • patients younger than 18 years old.
  • patients transferred directly to the ICU/Anesthesiology and Resuscitation Department after surgery without staying in the recovery room.
  • patients with incomplete medical documentation or missing blood pressure values in the recovery room.
  • patients with a pre-existing diagnosis of resistant hypotension or unstable hemodynamics before surgery
  • patients with a history of long-term use of anxiolytics, antipsychotics, or other psychotropic medications that may affect cognitive function, emotional state, or predictive outcomes
  • patient refusal to participate in the study (including cases where they initially consented), with an emphasis on respecting patient autonomy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of hypotension in the post-anesthesia care unit (PACU).

    Hypotension is defined as systolic blood pressure \<90 mmHg or a decrease of more than 20% from baseline values.

    Time frame: 0. postoperative day

Secondary outcomes

  1. Duration of the operation

    Duration of the surgical procedure as a risk factor for the development of postoperative hypotension. The duration will be recorded in minutes.

    Time frame: 0. postoperative day

  2. ASA classification (American Society of Anesthesiologists classification).

    ASA classification as a risk factor for the development of postoperative hypotension. ASA I: A normal healthy patient with no systemic disease. ASA II: A patient with mild systemic disease that does not limit daily activities (e.g., well-controlled diabetes or hypertension). ASA III: A patient with severe systemic disease that limits daily activities but is not incapacitating (e.g., poorly controlled diabetes or hypertension, chronic obstructive pulmonary disease). ASA IV: A patient with severe systemic disease that is a constant threat to life (e.g., unstable angina, symptomatic heart failure). ASA V: A moribund patient who is not expected to survive without surgery (e.g., ruptured abdominal aneurysm).

    Time frame: 0. postoperative day

  3. Type of anesthesia.

    The type of anesthesia used: general, regional, and/or peripheral nerve block.

    Time frame: 0. postoperative day

  4. Blood loss during the operation

    Blood loss during the surgical procedure, as documented in the surgical protocol.

    Time frame: 0. postoperative day

  5. Fluid balance during the surgery

    Fluid intake and output during surgery, measured in milliliters.

    Time frame: 0. postoperative day

  6. Surgical specialty

    Surgical specialties: neurosurgery, urology, gynecology, abdominal surgery, orthopedics

    Time frame: 0. postoperative day

  7. Fluid administration in the recovery room.

    Administration of a crystalloid or colloid bolus to augment intravascular volume.

    Time frame: 0. postoperative day

  8. Administration of vasopressors.

    In cases of severe hypotension, vasopressor administration (e.g., ephedrine, phenylephrine, norepinephrine) may be required to ensure adequate perfusion of vital organs.

    Time frame: 0. postoperative day

  9. Blood pressure monitoring.

    Repeated blood pressure measurement every 5 minutes.

    Time frame: 0. postoperative day

  10. Heart rate monitoring.

    Continuous heart rate monitoring.

    Time frame: 0. postoperative day

  11. Patient repositioning

    The Trendelenburg position (legs elevated above the head) can help increase venous return and consequently blood pressure. It will not be performed in surgeries involving the lower extremities.

    Time frame: 0. postoperative day

  12. Transfer of the patient to the ICU due to hemodynamic instability

    If hypotension does not improve despite repeated therapeutic interventions, escalation of care to the ICU may be necessary.

    Time frame: 0. postoperative day

  13. Postoperative nausea and vomiting

    Inadequate gastrointestinal perfusion can lead to nausea and vomiting, complicating the patient's recovery.

    Time frame: 0. postoperative day

  14. Impaired diuresis (oliguria, anuria)

    Oliguria is a medical term referring to low urine output, typically defined as producing less than 400-500 mL of urine per day in adults. Anuria is a medical condition characterized by the absence or near absence of urine production, typically defined as less than 100 mL of urine per day.

    Time frame: 0. postoperative day

  15. Impaired consciousness - GCS

    The Glasgow Coma Scale (GCS) is a clinical tool used to assess a person's level of consciousness after a brain injury. It evaluates three responses: eye opening, verbal response, and motor response, with scores ranging from 3 (deep coma) to 15 (fully alert).

    Time frame: 0. postoperative day

  16. Hypoxia

    Will be assessed using oxygen saturation levels (SpO₂). Mild hypoxia: SpO₂ 90-94% Moderate hypoxia:r SpO₂ 75-89% Severe hypoxia: SpO₂ \<75%

    Time frame: 0. postoperative day

  17. Lactic acidosis

    Lactic acidosis is a condition characterized by the accumulation of lactic acid in the bloodstream, leading to a decrease in blood pH. It can result from tissue hypoxia, impaired metabolism, or certain medical conditions. Lactic acidosis is generally defined by a serum lactate concentration above 4 mmol/L. Mild elevations in lactate (hyperlactatemia) occur at levels above 2 mmol/L, but true lactic acidosis is diagnosed when lactate levels exceed 4 mmol/L

    Time frame: 0. postoperative day

  18. Syncope

    Syncope is a temporary loss of consciousness due to a sudden decrease in blood flow to the brain. It typically has a rapid onset, short duration, and spontaneous recovery

    Time frame: 0. postoperative day

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for May 2026, 10 months after the start.

Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 10 months is below that.

Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2025
First posted
Jun 15, 2025
StartActual
Jun 15, 2025
Primary completionEst.
May 1, 2026
CompletionEst.
May 1, 2026
Last update
Jul 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07022210
Lead sponsor
Tomas Bata Hospital, Czech Republic
Responsible party
Klára Nekvindová (Deputy Chief for Science, Education, and Research, Tomas Bata Hospital, Czech Republic) — Principal investigator
First posted
Jun 15, 2025
Start date
Jun 15, 2025
Primary completion
May 1, 2026 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Jul 10, 2025

Study contacts

Klára Nekvindová, M.D., P.h.D.
Contact
nekvindova.klara@gmail.com
+420 577 551 111

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion